Showing results (1211-1220 of 1,473) with videos related to

Sort By:
Pageof 148
Human Molecular Genetics|February 6, 2009
The multimeric structure of polycystin-2 (TRPP2): structural-functional correlates of homo- and hetero-multimers with TRPC1Peng Zhang, Ying Luo, Bernard Chasan, et al.
Journal of the American Medical Informatics Association : JAMIA|September 29, 2022
Take on transplant: human-centered design of a patient education tool to facilitate informed discussions about lung transplant among people with cystic fibrosisAndrea L Hartzler, Lauren E Bartlett, Mara R Hobler, et al.
Genes|July 18, 2020
Co-Expression Networks for Causal Gene Identification Based on RNA-Seq Data of <i>Corynebacterium pseudotuberculosis</i>Edian F Franco, Pratip Rana, Ana Lidia Queiroz Cavalcante, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 2, 2025
Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the USNora C Burdis, Miranda C Bradford, Sonya L Heltshe, et al.
International Journal of Molecular Sciences|August 28, 2025
AI-Based Facial Phenotyping Supports a Shared Molecular Axis in <i>PACS1</i>-, <i>PACS2</i>-, and <i>WDR37</i>-Related SyndromesJulia Del Rincón, Marta Gil-Salvador, Cristina Lucia-Campos, et al.
Acta Otorrinolaringologica Espanola|October 6, 2004
[Primary nasal tuberculosis: a forgotten disease?]M J Agulles Fornés, M A Agut Fuster, E Grau Alario, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Design and implementation of an HIV/AIDS electronic medical record system (HIV/AIDS EMR) in the PhilippinesGelza Mae A Zabat, Janice Campos Caoili, Albert Anduyon, et al.
Transfusion|December 15, 2017
Quality management of a massive transfusion protocolJohn R Hess, Patrick J Ramos, Nina E Sen, et al.
Scientific Data|February 28, 2018
Holocene geochemical footprint from Semi-arid alpine wetlands in southern SpainAntonio García-Alix, Francisco J Jiménez-Espejo, Gonzalo Jiménez-Moreno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation studyJ Tabernero, F Ciardiello, F Rivera, et al.
Pageof 148